Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Other-Income-Expense-Net" stands at 71.78 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Daiichi Sankyo Co. Ltd.'s first quarter result of 8.73 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -65.96 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Daiichi Sankyo Co. Ltd.'s first quarter result of 8.73 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -49.29 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Daiichi Sankyo Co. Ltd.'s first quarter result of 71.78 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -10.57 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.24 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 10.24 Billion Japanese Yens.
The 3 year change is 104.64 Billion Japanese Yens.
The 5 year change is 178.17 Billion Japanese Yens.
The 10 year change is 209.43 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Other Income Expense Net | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Other Income Expense Net | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Other Income Expense Net | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |